Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 329

1.

Radioimmunotherapy in combination with reduced-intensity conditioning for allogeneic hematopoietic cell transplantation in patients with advanced multiple myeloma.

Fasslrinner F, Stölzel F, Kramer M, Teipel R, Brogsitter C, Morgner A, Arndt C, Bachmann M, Hänel M, Röllig C, Kotzerke J, Schetelig J, Bornhäuser M.

Biol Blood Marrow Transplant. 2019 Nov 12. pii: S1083-8791(19)30747-5. doi: 10.1016/j.bbmt.2019.11.007. [Epub ahead of print]

PMID:
31730919
2.

Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) in Patients with Therapy-Related Myeloid Neoplasm: A Study from the Chronic Malignancies Working Party of the EBMT.

Robin M, Wang J, Koster L, Beelen DW, Bornhäuser M, Kroeger N, Platzbecker U, Finke J, Ganser A, Blaise D, Ciceri F, Maertens J, Labussiere-Wallet H, Chevallier P, Passweg JR, Cornelissen JJ, Milpied N, Charbonnier A, Bonifazi F, de Wreede LC, Hayden P, Scheid C, Yakoub-Agha I.

Blood. 2019 Nov 13;134(Supplement_1):45. doi: 10.1182/blood-2019-124765.

PMID:
31724025
3.

Time from Diagnosis to Treatment Does Not Affect Outcome in Intensively Treated Patients with Newly Diagnosed Acute Myeloid Leukemia.

Röllig C, Kramer M, Schliemann C, Mikesch JH, Steffen B, Krämer A, Sauer T, Hänel M, Herbst R, Schäfer-Eckart K, Noppeney R, Jost E, Brümmendorf TH, Krause SW, Kunzmann V, Einsele H, Scholl S, Hochhaus A, Fransecky LR, Kaufmann M, Neubauer A, Niemann D, Schaich M, Frickhofen N, Kiani A, Heits F, Krümpelmann U, Kaiser U, Kullmer J, Wass M, Klein S, Von Bonin M, Middeke JM, Thiede C, Stoelzel F, Schetelig J, Ehninger G, Baldus CD, Müller-Tidow C, Platzbecker U, Serve H, Bornhäuser M.

Blood. 2019 Nov 13;134(Supplement_1):13. doi: 10.1182/blood-2019-123717.

PMID:
31724019
4.

Graft-versus-host disease and graft-versus-leukaemia effects in secondary acute myeloid leukaemia: a retrospective, multicentre registry analysis from the Acute Leukaemia Working Party of the EBMT.

Baron F, Labopin M, Savani BN, Beohou E, Niederwieser D, Eder M, Potter V, Kröger N, Beelen D, Socié G, Itälä-Remes M, Bornhäuser M, Mohty M, Nagler A.

Br J Haematol. 2019 Oct 14. doi: 10.1111/bjh.16185. [Epub ahead of print]

PMID:
31612473
5.

Modified DHAP regimen in the salvage treatment of refractory or relapsed lymphomas.

Kroschinsky F, Röllig D, Riemer B, Kramer M, Ordemann R, Schetelig J, Bornhäuser M, Ehninger G, Hänel M.

J Cancer Res Clin Oncol. 2019 Dec;145(12):3067-3073. doi: 10.1007/s00432-019-03027-6. Epub 2019 Sep 28.

PMID:
31563974
6.

The Evolving Landscape of Biomarkers for Anti-PD-1 or Anti-PD-L1 Therapy.

Tunger A, Sommer U, Wehner R, Kubasch AS, Grimm MO, Bachmann MP, Platzbecker U, Bornhäuser M, Baretton G, Schmitz M.

J Clin Med. 2019 Sep 25;8(10). pii: E1534. doi: 10.3390/jcm8101534. Review.

7.

Clostridium Difficile infections in patients with AML or MDS undergoing allogeneic hematopoietic stem cell transplantation identify high risk for adverse outcome.

Amberge S, Kramer M, Schröttner P, Heidrich K, Schmelz R, Middeke JM, Gunzer F, Hampe J, Schetelig J, Bornhäuser M, Stölzel F.

Bone Marrow Transplant. 2019 Sep 18. doi: 10.1038/s41409-019-0678-y. [Epub ahead of print]

PMID:
31534193
8.

Current State of Sarcoma Care in Germany: Results of an Online Survey of Physicians.

Eichler M, Richter S, Hohenberger P, Kasper B, Andreou D, Heidt V, Bornhäuser M, Schmitt J, Schuler MK.

Oncol Res Treat. 2019;42(11):589-598. doi: 10.1159/000502758. Epub 2019 Sep 11.

PMID:
31509840
9.

Reduced intensity conditioning regimens including alkylating chemotherapy do not alter survival outcomes after allogeneic hematopoietic cell transplantation in chronic lymphocytic leukemia compared to low-intensity non-myeloablative conditioning.

Andersen NS, Bornhäuser M, Gramatzki M, Dreger P, Vitek A, Karas M, Michallet M, Moreno C, van Gelder M, Henseler A, de Wreede LC, Schönland S, Kröger N, Schetelig J; CLL subcommittee, Chronic Malignancies Working Party.

J Cancer Res Clin Oncol. 2019 Nov;145(11):2823-2834. doi: 10.1007/s00432-019-03014-x. Epub 2019 Aug 29.

PMID:
31468122
10.

The prevalence of extramedullary acute myeloid leukemia detected by 18FDG-PET/CT: final results from the Prospective PETAML Trial.

Stölzel F, Lüer T, Löck S, Parmentier S, Kuithan F, Kramer M, Alakel NS, Sockel K, Taube F, Middeke JM, Schetelig J, Röllig C, Paulus T, Kotzerke J, Ehninger G, Bornhäuser M, Schaich M, Zoephel K.

Haematologica. 2019 Aug 29. pii: haematol.2019.223032. doi: 10.3324/haematol.2019.223032. [Epub ahead of print]

11.

T cells engrafted with a UniCAR 28/z outperform UniCAR BB/z-transduced T cells in the face of regulatory T cell-mediated immunosuppression.

Kegler A, Koristka S, Bergmann R, Berndt N, Arndt C, Feldmann A, Hoffmann A, Bornhäuser M, Schmitz M, Bachmann MP.

Oncoimmunology. 2019 Jun 7;8(9):e1621676. doi: 10.1080/2162402X.2019.1621676. eCollection 2019.

12.

Anti-CAR-engineered T cells for epitope-based elimination of autologous CAR T cells.

Koristka S, Ziller-Walter P, Bergmann R, Arndt C, Feldmann A, Kegler A, Cartellieri M, Ehninger A, Ehninger G, Bornhäuser M, Bachmann MP.

Cancer Immunol Immunother. 2019 Sep;68(9):1401-1415. doi: 10.1007/s00262-019-02376-y. Epub 2019 Aug 14.

13.

EZH2 mutations and impact on clinical outcome - an analysis in 1604 patients with newly diagnosed acute myeloid leukemia.

Stasik S, Middeke JM, Kramer M, Röllig C, Krämer A, Scholl S, Hochhaus A, Crysandt M, Brümmendorf TH, Naumann R, Steffen B, Kunzmann V, Einsele H, Schaich M, Burchert A, Neubauer A, Schäfer-Eckart K, Schliemann C, Krause S, Herbst R, Hänel M, Frickhofen N, Noppeney R, Kaiser U, Baldus CD, Kaufmann M, Rácil Z, Platzbecker U, Berdel WE, Mayer J, Serve H, Müller-Tidow C, Ehninger G, Bornhäuser M, Schetelig J, Thiede C.

Haematologica. 2019 Aug 14. pii: haematol.2019.222323. doi: 10.3324/haematol.2019.222323. [Epub ahead of print]

14.

Allogeneic HSCT for Autoimmune Diseases: A Retrospective Study From the EBMT ADWP, IEWP, and PDWP Working Parties.

Greco R, Labopin M, Badoglio M, Veys P, Furtado Silva JM, Abinun M, Gualandi F, Bornhauser M, Ciceri F, Saccardi R, Lankester A, Alexander T, Gennery AR, Bader P, Farge D, Snowden JA.

Front Immunol. 2019 Jul 4;10:1570. doi: 10.3389/fimmu.2019.01570. eCollection 2019.

15.

Effects of rigosertib on the osteo-hematopoietic niche in myelodysplastic syndromes.

Balaian E, Weidner H, Wobus M, Baschant U, Jacobi A, Mies A, Bornhäuser M, Guck J, Hofbauer LC, Rauner M, Platzbecker U.

Ann Hematol. 2019 Sep;98(9):2063-2072. doi: 10.1007/s00277-019-03756-1. Epub 2019 Jul 16.

PMID:
31312928
16.

Myeloablative and Reduced-Intensity Conditioned Allogeneic Hematopoietic Stem Cell Transplantation in Myelofibrosis: A Retrospective Study by the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation.

McLornan D, Szydlo R, Koster L, Chalandon Y, Robin M, Wolschke C, Beelen D, Socié G, Bornhäuser M, Angelucci E, Niederwieser D, Gerbitz A, Finke J, Vitek A, Itälä-Remes M, Radujkovic A, Kanz L, Potter V, Chevallier P, Stelljes M, Petersen E, Robinson S, Poiré X, Klyuchnikov E, Hernández-Boluda JC, Czerw T, Hayden P, Kröger N, Yakoub-Agha I.

Biol Blood Marrow Transplant. 2019 Nov;25(11):2167-2171. doi: 10.1016/j.bbmt.2019.06.034. Epub 2019 Jul 5.

PMID:
31284069
17.

Regulation of sclerostin in glucocorticoid-induced osteoporosis (GIO) in mice and humans.

Thiele S, Hannemann A, Winzer M, Baschant U, Weidner H, Nauck M, Thakker R, Bornhäuser M, Hofbauer L, Rauner M.

Endocr Connect. 2019 Jun 1. pii: EC-19-0104.R2. doi: 10.1530/EC-19-0104. [Epub ahead of print]

18.

Conditioning intensity and antilymphocyte globulin: towards personalized transplant strategies?

Bornhäuser M.

Haematologica. 2019 Jun;104(6):1101-1102. doi: 10.3324/haematol.2019.216952. No abstract available.

19.

Midostaurin abrogates CD33-directed UniCAR and CD33-CD3 bispecific antibody therapy in acute myeloid leukaemia.

Fasslrinner F, Arndt C, Koristka S, Feldmann A, Altmann H, von Bonin M, Schmitz M, Bornhäuser M, Bachmann M.

Br J Haematol. 2019 Sep;186(5):735-740. doi: 10.1111/bjh.15975. Epub 2019 May 23.

PMID:
31119728
20.

Second allogeneic stem cell transplantation in patients with acute lymphoblastic leukaemia: a study on behalf of the Acute Leukaemia Working Party of the European Society for Blood and Marrow Transplantation.

Nagler A, Labopin M, Dholaria B, Finke J, Brecht A, Schanz U, Niittyvuopio R, Neubauer A, Bornhäuser M, Santarone S, Beelen D, Shimoni A, Rösler W, Giebel S, Savani BN, Mohty M.

Br J Haematol. 2019 Sep;186(5):767-776. doi: 10.1111/bjh.15973. Epub 2019 May 22.

PMID:
31115916

Supplemental Content

Loading ...
Support Center